Octant
PrivateLast Round
Grant
Jun 11, 2025
Total Funding Raised
$119.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Octant operates in Healthcare & Life Sciences and is based in Emeryville, California. Its latest recorded funding round was a Grant round in June 2025.
Octant is a biotechnology company that develops synthetic biology and machine learning platforms to engineer small-molecule therapeutics for complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Octant Comparables
Compare Octant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Superluminal Medicines | 83% | |
| Terray Therapeutics | 83% | |
| Genesis Therapeutics | 82% |
For institutional investors. Book with your work email.
Octant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 11, 2025 | ||||
| Series B | Apr 21, 2022 | ||||
| Series A | May 20, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Octant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B, Series A |
| SV Angel | Series A |
| Allen & Company | Series B, Series A |
| Gaingels | Series B |
| Gates Family Foundation | Grant |
| Catalio Capital Management | Series B |
| Bill & Melinda Gates Foundation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 39% MoM, reaching 11.8K.
- Jul 27, 2026
Monthly visitors grew 35% MoM, reaching 8.5K.
For institutional investors. Book with your work email.
Octant Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Octant's valuation, stock price, and market status.
Is Octant a public or private company?
Octant is a private company.
What is the current stock price of Octant?
Octant is a private company, so its shares have no public market price. Caplight tracks Octant's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Octant worth (valuation)?
Valuation information for Octant is not publicly available.
Can I buy Octant stock?
Octant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Octant's last funding round?
Octant's most recent funding round was Grant on June 11, 2025.
Who are the main investors in Octant?
Key investors in Octant include Andreessen Horowitz, Catalio Capital Management.
Will Octant IPO soon?
No public IPO plans have been announced for Octant.
How can I track Octant secondary market activity?
Caplight tracks bids, offers, and trades in Octant's shares on secondary markets.